Cas 867164-35-0,3-((1s,3s)-3-(4-Methylpiperazin-1-yl)cyclobutyl)-1-(2-phenylquinolin-7-yl)iMidazo[1,5-a]pyrazin-8-aMine

867164-35-0

Post Buying Request

Basic information

Product Name: 3-((1s,3s)-3-(4-Methylpiperazin-1-yl)cyclobutyl)-1-(2-phenylquinolin-7-yl)iMidazo[1,5-a]pyrazin-8-aMine
Synonyms: 3-((1s,3s)-3-(4-Methylpiperazin-1-yl)cyclobutyl)-1-(2-phenylquinolin-7-yl)iMidazo[1,5-a]pyrazin-8-aMine;PQIP
CAS NO:867164-35-0
Molecular Formula: C30H31N7
Molecular Weight: 489.61404
EINECS: -0
Product Categories: N/A

Chemical Properties

Melting Point: N/A
Boiling Point: N/A
Flash Point: N/A
Appearance: /
Density: N/A
Refractive Index: N/A
Storage Temp.: N/A
Solubility: N/A
CAS DataBase Reference: 3-((1s,3s)-3-(4-Methylpiperazin-1-yl)cyclobutyl)-1-(2-phenylquinolin-7-yl)iMidazo[1,5-a]pyrazin-8-aMine(CAS DataBase Reference)
NIST Chemistry Reference: 3-((1s,3s)-3-(4-Methylpiperazin-1-yl)cyclobutyl)-1-(2-phenylquinolin-7-yl)iMidazo[1,5-a]pyrazin-8-aMine(867164-35-0)
EPA Substance Registry System: 3-((1s,3s)-3-(4-Methylpiperazin-1-yl)cyclobutyl)-1-(2-phenylquinolin-7-yl)iMidazo[1,5-a]pyrazin-8-aMine(867164-35-0)

Safety Data

Hazard Codes: N/A
Statements: N/A
Safety Statements: N/A
WGK Germany:
RTECS:
HazardClass: N/A
PackingGroup: N/A
Hazardous Substances Data: 867164-35-0(Hazardous Substances Data)

Suppliers
Usage
Upstream product
Downstream Products
Article

867164-35-0 Suppliers

Recommended suppliers

867164-35-0 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 867164-35-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,6,7,1,6 and 4 respectively; the second part has 2 digits, 3 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 867164-35:
(8*8)+(7*6)+(6*7)+(5*1)+(4*6)+(3*4)+(2*3)+(1*5)=200
200 % 10 = 0
So 867164-35-0 is a valid CAS Registry Number.

867164-35-0Upstream product

867164-35-0Downstream Products

867164-35-0Relevant academic research and scientific papers

6,6-BICYCLIC RING SUBSTITUTED HETEROBICYCLIC PROTEIN KINASE INHIBITORS

-

Page/Page column 365; 368, (2008/06/13)

Compounds of the formula (I) and pharmaceutically acceptable salts thereof, wherein XI, X2, X3, X4, X5, X6, X7, R1, and Q1 are defined herein, inhibit the IGF-1R enzyme and are useful for the treatment and/or prevention of hyperproliferative diseases such as cancer, inflammation, psoriasis, allergy/asthma, disease and conditions of the immune system, disease and conditions of the central nervous system.

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 867164-35-0